DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2005/0215635 A1 Rafi Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2005/0215635 A1 Rafi Et Al US 20050215635A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0215635 A1 Rafi et al. (43) Pub. Date: Sep. 29, 2005 (54) DIARYLHEPTANOID COMPOUNDS AND Publication Classification USES THEREOF (76) Inventors: M. Mohamed Rafi, Highland Park, NJ (51) Int. Cl." .......................... A61K 31/22; A61K 31/12 (US); Zhihua Liu, Howell, NJ (US); (52) U.S. Cl. ............................................ 514/546; 514/690 Robert T. Rosen, Monroe Township, NJ (US); Sharon L. Rosen, legal representative, (US); Chi-Tang Ho, (57) ABSTRACT East Brunswick, NJ (US) Correspondence Address: JONES DAY The present invention relates to diarylheptanoid compounds 222 EAST 41ST ST and compositions comprising a diarylheptanoid compound. NEW YORK, NY 10017 (US) The present invention also relates to methods for preventing or treating various diseases and disorders by administering (21) Appl. No.: 11/075,275 to a Subject in need thereof one or more diarylheptanoid compounds. In particular, the invention relates to methods (22) Filed: Mar. 8, 2005 for preventing or treating cancer or an inflammatory disorder Related U.S. Application Data by administering to a Subject in need thereof one or more diarylheptanoid compounds. The present invention further (60) Provisional application No. 60/551,182, filed on Mar. relates to articles of manufacture comprising one or more 8, 2004. diarylheptanoid compounds. Patent Application Publication Sep. 29, 2005 Sheet 1 of 6 US 2005/0215635 A1 Figure 1 Fraction 2 Fraction 1 Fraction 3 Patent Application Publication Sep. 29, 2005 Sheet 2 of 6 US 2005/0215635 A1 Figure 2 Control HMP (6.25 uM) HMP (12.5 uM) HMP (25 uM) Patent Application Publication Sep. 29, 2005 Sheet 3 of 6 US 2005/0215635 A1 Figure 3 COX-2 3-Actin iNOS B-Actin Patent Application Publication Sep. 29, 2005 Sheet 4 of 6 US 2005/0215635 A1 Figure 4A iNOS COX-2 Controls LPS (0.5 ug/ml) H.LPS+HMP (12.5 uM) is LPS+HMP (25 uM) Patent Application Publication Sep. 29, 2005 Sheet 5 of 6 US 2005/0215635 A1 Figure 5 O -- + HMP (25 uM) -- -- -- -- + LPS (0.5ug/ml) A 0 15 30 60 30 60 Time (min) pp44/42 p44/42 11 24. 1 Yse 2 O Control LPS-15 min LPS-30 min LPS-60 min LPSHMP- LPSHMP 30 min 6O min Patent Application Publication Sep. 29, 2005 Sheet 6 of 6 US 2005/0215635 A1 Figure 6 A 16 B 14 8 O. 17 Control LPS LPS+HMP (25 LPS+HMP - uM) (12.5 uM) US 2005/0215635 A1 Sep. 29, 2005 DARYLHEPTANOD COMPOUNDS AND USES The inflammatory response is characterized by increased THEREOF blood flow, increased capillary permeability, and the influx 0001. This application is entitled to and claims priority to of phagocytic cells. These events result in Swelling, redness, U.S. provisional Ser. No. 60/551,182, filed Mar. 8, 2004, warmth (altered heat patterns), and pus formation at the site which is incorporated by reference herein in its entirety. of injury or infection. 0007. A delicate well-balanced interplay between the 1. FIELD OF THE INVENTION humoral and cellular immune elements in the inflammatory 0002 The present invention relates to diarylheptanoid response enables the elimination of harmful agents and the compounds and compositions comprising a diarylheptanoid initiation of the repair of damaged tissue. When this deli compound. The present invention also relates to methods for cately balanced interplay is disrupted, the inflammatory preventing or treating various diseases and disorders by response may result in considerable damage to normal tissue administering to a Subject in need thereof one or more and may be more harmful than the original insult that diarylheptanoid compounds. In particular, the invention initiated the reaction. In these cases of uncontrolled inflam relates to methods for preventing or treating a cell prolif matory responses, clinical intervention is needed to prevent erative disorder or an inflammatory disorder by administer tissue damage and organ dysfunction. DiseaseS Such as ing to a Subject in need thereof one or more diarylheptanoid rheumatoid arthritis, Osteoarthritis, Crohn's disease, asthma, compounds. The present invention further relates to kits allergies or inflammatory bowel disease, are characterized comprising one or more diarylheptanoid compounds. by chronic inflammation. 0008 Current treatments for inflammatory disorders 2. BACKGROUND OF THE INVENTION involve Symptomatic medications and immunosuppressive agents to control Symptoms. For example, nonsteroidal 2.1 Cancer and Neoplastic Disease anti-inflammatory drugs (NSAIDs) Such as aspirin, ibupro 0.003 Cancer is the second leading cause of death in the fen, fenoprofen, naproxen, tolmetin, Sulindac, meclofe United States. The American Cancer Society estimated that namate Sodium, piroXicam, flurbiprofen, diclofenac, in 2001, there would be 1.3 million new cases of cancer and Oxaprozin, nabumetone, etodolac, and ketoprofen have anal that cancer would cause 550,000 deaths. Overall rates have gesic and anti-inflammatory effects. However, NSAIDs are declined by 1% per year during the 1990s. There are 9 believed not to be capable of altering progression of the million Americans alive who have ever had cancer. NIH disease. (Tierney et al. (eds), Current Medical Diagnosis & estimates the direct medical costs of cancer as S60 billion. Treatment, 37 ed., Appleton & Lange (1998), p793). More 0004 Currently, cancer therapy involves Surgery, chemo over, NSAIDS frequently cause gastrointestinal Side effects. therapy and/or radiation treatment to eradicate neoplastic Corticosteroids are another class of drugs that are commonly cells in a patient (see, for example, Stockdale, 1998, “Prin used to control inflammatory Symptoms. Corticosteroids, ciples of Cancer Patient Management”, in Scientific Ameri like NSAIDs, do not alter the natural progression of the disease, and thus, clinical manifestations of active disease can. Medicine, vol. 3, Rubenstein and Federman, eds., commonly reappear when the drug is discontinued. Low Chapter 12, Section IV). All of these approaches pose doses of immunosuppressive agents Such as cytotoxic agents Significant drawbacks for the patient. are also commonly used to in treatment of inflammatory 0005. Despite the availability of a variety of chemothera disorders. Many cytotoxic agents, frequently causes Stoma peutic agents, traditional chemotherapy has many draw titis, erythema, Slopecia, nausea, vomiting, diarrhea, and backs (see, for example, Stockdale, 1998, “Principles Of damage to major organs Such kidney and liver. The long Cancer Patient Management” in Scientific American Medi term usage of immunosuppressive agents usually leaves the cine, Vol. 3, Rubenstein and Federman, eds., ch. 12, Sect. patient defenseless to infections. 10). Almost all chemotherapeutic agents are toxic, and chemotherapy can cause significant, and often dangerous, 0009 New treatment and preventative modalities for Side effects, including Severe nausea, bone marrow depres inflammatory disorders are constantly being Sought. In par Sion, immunosuppression, etc. Additionally, many tumor ticular, any new modalities that reduces the dosage and/or cells are resistant or develop resistance to chemotherapeutic frequency of administration of agents currently being used, agents through multi-drug resistance. Therefore, there is a or is capable of making a currently used treatment and/or Significant need in the art for novel compounds and com prevention more effective is constantly being Sought. positions, and methods that are useful for treating cancer or 0010. The use of herbal therapy or alternative medicine is neoplastic disease with minimal or no side effects. Further, becoming an increasingly attractive approach for the treat there is a need for cancer treatments that provide cancer ment of various inflammatory disorders. The majority of cell-specific therapies with increased Specificity and naturally occurring phenolics in different plants possess decreased toxicity. tremendous antioxidative and anti-inflammatory activities (Surh et al., 2001). Anti-inflammatory properties of various 2.2 Inflammatory Disorders phytochemicals are mediated through the inhibition of pro 0006 Inflammation plays a fundamental role in host duction of cytokines (IL-1 B, TNF-C., IL-6, IL-12, IFN-Y), defenses and the progression of immune-mediated diseases. nitric oxide (NO), prostaglandins and leukotriens. Antioxi The inflammatory response is initiated in response to injury dants Such as (-)-epigallocatechin-3-gallate (EGCG) (Lin (e.g., trauma, ischemia, and foreign particles) and infection and Lin, 1997), resveratrol (Tsai et al., 1999) and naturally (e.g., bacterial or viral infection) by a complex cascade of occurring flavonoids including apigenin and kaempferol events, including chemical mediators (e.g., cytokines and (Liang et al., 1999) have been reported to suppress NO prostaglandins) and inflammatory cells (e.g., leukocytes). production through inhibition of nuclear factor-kappa B US 2005/0215635 A1 Sep. 29, 2005 (NF-kB). Earlier studies have shown that ginger and its 3. SUMMARY OF THE INVENTION constituents are potent inhibitors of immune cell activation and cytokine Secretion and used for the treatment of cancer 0013 The present invention provides methods of using (Ageel et al., 1989). Pharmacologically, ginger (Zingiber diarylheptanoid compounds in the prevention, treatment or Oficinale), Similar to other plants, possess very complex management of various disorders. The present invention mixture of compounds. This plant contains Several hundred provides certain novel diarylheptanoid
Load more

Recommended publications
  • Influence of Whole-Wheat Consumption on Fecal Microbial Community
    Influence of whole-wheat consumption on fecal microbial community structure of obese diabetic mice Jose F. Garcia-Mazcorro1,2, Ivan Ivanov3, David A. Mills4 and Giuliana Noratto5,# 1 Faculty of Veterinary Medicine, Universidad Auto´noma de Nuevo Leo´n, General Escobedo, Nuevo Leon, Mexico 2 Research Group Medical Eco-Biology, Universidad Auto´noma de Nuevo Leo´n, General Escobedo, Nuevo Leon, Mexico 3 Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas, United States 4 Department of Food Science and Technology, University of California, Davis, Davis, California, United States 5 School of Food Science, Washington State University, Pullman, Washington, United States # Current Address: Nutrition and Food Science, Texas A&M University, College Station, Texas, United States ABSTRACT The digestive tract of mammals and other animals is colonized by trillions of metabolically-active microorganisms. Changes in the gut microbiota have been associated with obesity in both humans and laboratory animals. Dietary modifications can often modulate the obese gut microbial ecosystem towards a more healthy state. This phenomenon should preferably be studied using dietary ingredients that are relevant to human nutrition. This study was designed to evaluate the influence of whole-wheat, a food ingredient with several beneficial properties, on gut microorganisms of obese diabetic mice. Diabetic (db/db) mice were fed standard (obese-control) or whole-wheat isocaloric diets (WW group) for eight weeks; Submitted 28 October 2015 non-obese mice were used as control (lean-control). High-throughput sequencing Accepted 27 January 2016 using the MiSeq platform coupled with freely-available computational tools and Published 15 February 2016 quantitative real-time PCR were used to analyze fecal bacterial 16S rRNA gene Corresponding authors sequences.
    [Show full text]
  • The Genus Alpinia: a Review of Its Phytochemistry and Pharmacology
    DOI: 10.15806/j.issn.2311-8571.2015.0026 World J Tradit Chin Med 2016; 2(1): 26–41 Modern Research on Chinese Materia Medica The Genus Alpinia: A Review of Its Phytochemistry and Pharmacology Wei-Jie Zhanga, Jian-Guang Luoa and Ling-Yi Kong* aState Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China *Correspondence: Prof. Ling-Yi Kong, Department of Natural Medicinal Chemistry,China Pharmaceutical University,24 Tong Jia Xiang, Nanjing 210009, China, E-mail: [email protected] ABSTRACT Genus Alpinia consists of over 250 species, which are widely distributed in south and southeast Asia. Many plants of genus Alpinia have been used for thousands of years to treat digestive system diseases and as anti-inflammatory drugs. Phytochemical research on this genus has led to the isolation of different kinds of diarylheptanoids, terpenes triterpenoids, phenylbutanoids, lignans, and flavonoids. Experimental evidences revealed that both the crude extracts and pure constituents isolated from the genus Alpinia exhibit a wide range of bioactivities such as anti- cancer, anti-oxidant, anti-bacterial, anti-viral, cardiovascular, and digestive system protective effects. Here, we summarize the phytochemistry and pharmacology investigation of the genus Alpinia, which can provide reference for further research and drug development. Key words: Genus Alipinia, phytochemistry, pharmacology, a review Received 3 August 2015; Accept 2 March 2016 INTRODUCTION review, the conclusion can be drawn that, diarylheptanoids, terpenes and flavonoids are abundant in this genus. Genus Alpinia is a large genus of the Zingiberaceae family, which is widely distributed in many tropical regions of Asia, including China, India and Indonesia.
    [Show full text]
  • Fitoterapia 145 (2020) 104610
    Fitoterapia 145 (2020) 104610 Contents lists available at ScienceDirect Fitoterapia journal homepage: www.elsevier.com/locate/fitote Flavonoid, stilbene and diarylheptanoid constituents of Persicaria maculosa T Gray and cytotoxic activity of the isolated compounds Andrea Vasasa, Ildikó Lajtera, Norbert Kúsza, Péter Forgóa, Gusztáv Jakabb, Csilla Fazakasc, ⁎ Imola Wilhelmc,d, István A. Krizbaic,d, Judit Hohmanna,e, a Department of Pharmacognosy, University of Szeged, H-6720 Szeged, Hungary b Institute of Environmental Sciences, Faculty of Agricultural Water and Environmental Management, Tessedik Samuel College, H-5540 Szarvas, Hungary c Institute of Biophysics, Biological Research Centre, H-6726 Szeged, Hungary d Institute of Life Sciences, Vasile Goldiş Western University of Arad, RO-310414 Arad, Romania e Interdisciplinary Centre of Natural Products, University of Szeged, H-6720 Szeged, Hungary ARTICLE INFO ABSTRACT Keywords: Persicaria maculosa (Polygonaceae) has been used as edible and as medicinal plant since ancient times. As a result Persicaria maculosa of multistep chromatographic purifications, chalcones [2′-hydroxy-3′,4′,6′-trimethoxychalcone (1), pashanone Flavanones (2), pinostrobin chalcone (3)], flavanones [6-hydroxy-5,7-dimethoxyflavanone (4), pinostrobin (5), onysilin (6), Chalcones 5-hydroxy-7,8-dimethoxyflavanone (7)], flavonol [3-O-methylgalangin (8)], stilbene [persilben (9)], dia- Stilbene rylheptanoids [1,7-diphenylhept-4-en-3-one (10), dihydroyashabushiketol (12), yashabushidiol B (13)] and 3- Diarylheptanoids oxo-α-ionol-glucoside (11) were isolated from P. maculosa. The present paper reports for the first time the Cytotoxicity occurrence of diarylheptanoid-type constituents in the family Polygonaceae. Cytotoxicity of 1–5, 7 and 9–11 on 4 T1 mouse triple negative breast cancer cells was assayed by MTT test.
    [Show full text]
  • Synthesis of Natural and Non-Natural Diarylheptanoids and Evaluation of Their Neuroprotective Activity
    Synthesis of natural and non-natural diarylheptanoids and evaluation of their neuroprotective activity Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) der Fakultät für Chemie und Pharmazie der Universität Regensburg vorgelegt von Petr Jirásek aus Prag 2014 Gedruckt mit Unterstützung des Deutschen Akademischen Austauschdienstes Die vorliegende Arbeit wurde im Zeitraum vom Januar 2011 bis September 2014 unter der Leitung von Prof. Dr. Jörg Heilmann und PD Dr. Sabine Amslinger am Lehrstuhl für Pharmazeutische Biologie und am Institut für Organische Chemie der Universität Regensburg angefertigt. Das Promotionsgesuch wurde eingereicht am: Tag der mündlichen Prüfung: 29.09.2014 Prüfungsausschuss: Prof. Dr. Jörg Heilmann (Erstgutachter) PD Dr. Sabine Amsliger (Zweitgutachter) Prof. Dr. Sigurd Elz (dritter Prüfer) Prof. Dr. Siavosh Mahboobi (Vorsitzender) Danksagung An dieser Stelle möchte ich mich bei allen Personen bedanken, die zum Gelingen dieser Arbeit beigetragen haben: bei Prof. Dr. Jörg Heilmann für die Vergabe dieses spannenden Themas, für viele wertvolle Anregungen, sein Vertrauen und für die schöne Jahre in seiner Arbeitsgruppe; bei PD Dr. Sabine Amslinger für die lehrreiche Zeit in Ihrem Umfeld, für all die Hilfe in Sachen organischer Chemie und für die herzliche Aufnahme in Ihrem Arbeitskreis; mein besonderer Dank gilt dem Deutschen Akademischen Austauschdienst für die Finanzierung meiner Promotion; bei allen jetzigen und ehemaligen Kolleginen und Kollegen am Lehrstuhl für Pharmazeutische Biologie möchte ich mich für das besonders freundliche Arbeitsklima und ihre Hilfsbereitschaft ganz herzlich bedanken; mein Dank gilt natürlich auch meinen Laborkolleginen und Laborkollegen von AK Amslinger für die angenehme Laborzeit und viele anregende Disskusionen; bei Frau Gabriele Brunner für ihre Geduld und Hilfe bei allen praktischen Aspekten der alltägigen Laborarbeit, genauso wie bei Frau Anne Grashuber für ihre unabdingbare und freundliche Unterstützung bei der Betreung der Praktika; weiterhin möchte ich mich bei Dr.
    [Show full text]
  • Promising Natural Products As Anti-Cancer Agents Against Neuroblastoma
    In: Horizons in Cancer Research. Volume 59 ISBN: 978-1-63483-093-5 Editor: Hiroto S. Watanabe © 2015 Nova Science Publishers, Inc. Chapter 6 Promising Natural Products As Anti-Cancer Agents against Neuroblastoma Ken Yasukawa* and Keiichi Tabata Nihon University School of Pharmacy, Narashinodai, Funabashi, Chiba, Japan Abstract Neuroblastoma is a neuroendocrine tumor arising from neural crest elements of the sympathetic nervous system (SNS). It most frequently originates in one of the adrenal glands, but can also develop in nerve tissues of the neck, chest, abdomen or pelvis, and exhibits extreme heterogeneity, being stratified into three risk categories; low, intermediate, and high. Low-risk disease is most common in infants and good outcomes are common with observation only or surgery, whereas high-risk disease is difficult to treat successfully, even with the most intensive multi-modal therapies available. Esthesioneuroblastoma, also known as olfactory neuroblastoma, is believed to arise from the olfactory epithelium and its classification remains controversial. However, as it is not a sympathetic nervous system malignancy, esthesioneuroblastoma is a distinct clinical entity and is not to be confused with neuroblastoma. This review describes novel natural products with which neuroblastoma can be treated. Abbreviations AIF Apoptosis-inducing factor AMPK Adenosine monophosphate kinase ATF3 Activating transcription factor 3 * E-mail: [email protected], yasukawa.ken@nihon-u,ne.jp. 92 Ken Yasukawa and Keiichi Tabata Bcl-2 B-cell
    [Show full text]
  • Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza Glabra L., Paeonia Lactiflora Pall., and Eriobotrya Japonica (Thunb.) Lindl
    Medicines 2019, 6, 43; doi:10.3390/medicines6020043 S1 of S35 Supplementary Materials: Antioxidant, Cytotoxic, and Antimicrobial Activities of Glycyrrhiza glabra L., Paeonia lactiflora Pall., and Eriobotrya japonica (Thunb.) Lindl. Extracts Jun-Xian Zhou, Markus Santhosh Braun, Pille Wetterauer, Bernhard Wetterauer and Michael Wink T r o lo x G a llic a c id F e S O 0 .6 4 1 .5 2 .0 e e c c 0 .4 1 .5 1 .0 e n n c a a n b b a r r b o o r 1 .0 s s o b b 0 .2 s 0 .5 b A A A 0 .5 0 .0 0 .0 0 .0 0 5 1 0 1 5 2 0 2 5 0 5 0 1 0 0 1 5 0 2 0 0 0 1 0 2 0 3 0 4 0 5 0 C o n c e n tr a tio n ( M ) C o n c e n tr a tio n ( M ) C o n c e n tr a tio n ( g /m l) Figure S1. The standard curves in the TEAC, FRAP and Folin-Ciocateu assays shown as absorption vs. concentration. Results are expressed as the mean ± SD from at least three independent experiments. Table S1. Secondary metabolites in Glycyrrhiza glabra. Part Class Plant Secondary Metabolites References Root Glycyrrhizic acid 1-6 Glabric acid 7 Liquoric acid 8 Betulinic acid 9 18α-Glycyrrhetinic acid 2,3,5,10-12 Triterpenes 18β-Glycyrrhetinic acid Ammonium glycyrrhinate 10 Isoglabrolide 13 21α-Hydroxyisoglabrolide 13 Glabrolide 13 11-Deoxyglabrolide 13 Deoxyglabrolide 13 Glycyrrhetol 13 24-Hydroxyliquiritic acid 13 Liquiridiolic acid 13 28-Hydroxygiycyrrhetinic acid 13 18α-Hydroxyglycyrrhetinic acid 13 Olean-11,13(18)-dien-3β-ol-30-oic acid and 3β-acetoxy-30-methyl ester 13 Liquiritic acid 13 Olean-12-en-3β-ol-30-oic acid 13 24-Hydroxyglycyrrhetinic acid 13 11-Deoxyglycyrrhetinic acid 5,13 24-Hydroxy-11-deoxyglycyirhetinic
    [Show full text]
  • Natural Phenolic Metabolites with Anti-Angiogenic Properties – a Review from the Chemical Point of View
    Natural phenolic metabolites with anti-angiogenic properties – a review from the chemical point of view Qiu Sun1, Jörg Heilmann2 and Burkhard König*1 Review Open Access Address: Beilstein J. Org. Chem. 2015, 11, 249–264. 1Institute of Organic Chemistry, University of Regensburg, doi:10.3762/bjoc.11.28 Universitätsstr. 31, 93053 Regensburg, Germany and 2Institute of Pharmacy, University of Regensburg, Universitätsstr. 31, 93053 Received: 18 December 2014 Regensburg, Germany Accepted: 27 January 2015 Published: 16 February 2015 Email: Burkhard König* - [email protected] Associate Editor: J. S. Dickschat * Corresponding author © 2015 Sun et al; licensee Beilstein-Institut. License and terms: see end of document. Keywords: angiogenesis; natural phenolic compounds; structure–activity relationship; synthesis Abstract Considering the many secondary natural metabolites available from plants, phenolic compounds play a particularly important role in human health as they occur in significant amounts in many fruits, vegetables and medicinal plants. In this review natural phenolic compounds of plant origin with significant anti-angiogenic properties are discussed. Thirteen representatives from eight different natural or natural-like phenolic subclasses are presented with an emphasis on their synthesis and methods to modify the parent com- pounds. When available, the consequence of structural variation on the pharmacological activity of the molecules is described. Introduction The term angiogenesis is commonly used to describe the bio- The generation of new blood vessels is based on a strictly logical process of blood vessel growth. Nevertheless, it should controlled balance between various soluble and membrane- be more precisely defined as the formation of new blood vessels bound factors showing either anti- or pro-angiogenic activity, from preexisting ones.
    [Show full text]
  • Mechanisms of Herbal Nephroprotection in Diabetes Mellitus
    Hindawi Journal of Diabetes Research Volume 2020, Article ID 5710513, 31 pages https://doi.org/10.1155/2020/5710513 Review Article Mechanisms of Herbal Nephroprotection in diabetes mellitus Dorin Dragoș ,1,2 Maria Mirabela Manea ,1,3 Delia Timofte ,4 and Dorin Ionescu 1,2 1Faculty of General Medicine, “Carol Davila” University of Medicine and Pharmacy, str. Dionisie Lupu nr. 37, sect 1, Bucharest 020021, Romania 2Nephrology Clinic of University Emergency Hospital, Splaiul Independentei nr. 169, sect. 5, Bucharest 050098, Romania 3National Institute of Neurology and Cerebrovascular Diseases, Şos. Berceni, Nr. 10-12, Sector 4, Bucharest 041914, Romania 4Dialysis Department of University Emergency Hospital, Splaiul Independentei nr. 169, sect. 5, Bucharest 050098, Romania Correspondence should be addressed to Maria Mirabela Manea; [email protected] Received 28 January 2020; Revised 24 May 2020; Accepted 6 June 2020; Published 6 July 2020 Academic Editor: Eric Hajduch Copyright © 2020 Dorin Dragoș et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Diabetic nephropathy (DN) is a leading cause of kidney morbidity. Despite the multilayered complexity of the mechanisms involved in the pathogenesis of DN, the conventional treatment is limited to just a few drug classes fraught with the risk of adverse events, including the progression of renal dysfunction. Phytoceuticals offer a promising alternative as they act on the many-sidedness of DN pathophysiology, multitargeting its intricacies. This paper offers a review of the mechanisms underlying the protective action of these phytoagents, including boosting the antioxidant capabilities, suppression of inflammation, averting the proliferative and sclerosing/fibrosing events.
    [Show full text]
  • Zingiber Officinale
    Metabolomic analysis of bioactive compounds in mature rhizomes and daughter rhizomes in ginger (Zingiber ocinale) Zhexin Li Chongqing University of Arts and Sciences https://orcid.org/0000-0002-5097-8571 Ze-Xiong Chen Chongqing University of Arts and Sciences Jian-Min Tang Chongqing University of Arts and Sciences Yu-Song Jiang Chongqing University of Arts and Sciences Qin-Hong Liao Chongqing University of Arts and Sciences Yi-Qing Liu Yangtze University Guo-Hua Liu ( [email protected] ) Research article Keywords: ginger, rhizome, daughter rhizome, bioactive compounds, metabolomic analysis Posted Date: November 19th, 2019 DOI: https://doi.org/10.21203/rs.2.17463/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/18 Abstract Background The bioactive compounds of ginger (Zingiber ocinale), such as gingerols, diarylheptanoids, and avonoids, are of importance to human health because of their anticancer, antioxidant, and anti- inammatory properties. The daughter rhizomes arise from mature rhizomes, but the pungency and pharmacological quality of the two rhizome types differ substantially. Results In this study, a metabolomic analysis was performed to investigate the biosynthesis of major bioactive compounds in the mature rhizome (R) and daughter rhizome (DR) in ginger. A total of 1212 differentially accumulated metabolites with p < 0.05 and |fold change| ≥ 1 were identied, of which 399 metabolites were more highly accumulated in R samples than in DR samples, whereas 211 metabolites were most highly accumulated in DR samples. Metabolic pathways associated with the bioactive compounds that determine the pharmacological activity of ginger, including the “terpenoid backbone biosynthesis”, “stilbenoid, diarylheptanoid, and gingerol biosynthesis”, and "avonoid biosynthesis" pathways, were enriched in R samples, which indicated that bioactive compounds mainly accumulated in mature rhizomes of ginger.
    [Show full text]
  • Screening of Phenolic Compounds in Australian Grown Berries by LC-ESI-QTOF-MS/MS and Determination of Their Antioxidant Potential
    antioxidants Article Screening of Phenolic Compounds in Australian Grown Berries by LC-ESI-QTOF-MS/MS and Determination of Their Antioxidant Potential Vigasini Subbiah 1, Biming Zhong 1, Malik A. Nawaz 2 , Colin J. Barrow 3 , Frank R. Dunshea 1,4 and Hafiz A. R. Suleria 1,3,* 1 Faculty of Veterinary and Agricultural Sciences, School of Agriculture and Food, The University of Melbourne, Parkville, VIC 3010, Australia; [email protected] (V.S.); [email protected] (B.Z.); [email protected] (F.R.D.) 2 Commonwealth Scientific and Industrial Research Organisation (CSIRO), Agriculture and Food, 671 Sneydes Road, Private Bag 16, Werribee, VIC 3030, Australia; [email protected] 3 Centre for Chemistry and Biotechnology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC 3217, Australia; [email protected] 4 Faculty of Biological Sciences, The University of Leeds, Leeds LS2 9JT, UK * Correspondence: hafi[email protected]; Tel.: +61-470-439-670 Abstract: Berries are grown worldwide with the most consumed berries being blackberries (Rubus spp.), blueberries (Vaccinium corymbosum), red raspberries (Rubus idaeus) and strawberries (Fragaria spp.). Berries are either consumed fresh, frozen, or processed into wines, juices, and jams. In recent times, researchers have focused their attention on berries due to their abundance in phenolic compounds. The current study aimed to evaluate the phenolic content and their antioxidant potential followed by characterization and quantification using LC-ESI-QTOF-MS/MS and HPLC-PDA. Blueberries were µ Citation: Subbiah, V.; Zhong, B.; highest in TPC (2.93 ± 0.07 mg GAE/gf.w.) and TFC (70.31 ± 1.21 g QE/gf.w.), whereas the blackber- Nawaz, M.A.; Barrow, C.J.; Dunshea, ries had the highest content in TTC (11.32 ± 0.13 mg CE/gf.w.).
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis Chemical Activity Count (+)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (+)-8HYDROXYCALAMENENE 1 (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 3 (+)-AROMOLINE 1 (+)-CASSYTHICINE 1 (+)-CATECHIN 10 (+)-CATECHIN-7-O-GALLATE 1 (+)-CATECHOL 1 (+)-CEPHARANTHINE 1 (+)-CYANIDANOL-3 1 (+)-EPIPINORESINOL 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALBACIN 2 (+)-GALLOCATECHIN 3 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 2 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 2 (+)-T-CADINOL 1 (+)-VESTITONE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (-)-ACANTHOCARPAN 1 (-)-ALPHA-BISABOLOL 2 (-)-ALPHA-HYDRASTINE 1 Chemical Activity Count (-)-APIOCARPIN 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-CANESCACARPIN 1 (-)-CENTROLOBINE 1 (-)-CLANDESTACARPIN 1 (-)-CRISTACARPIN 1 (-)-DEMETHYLMEDICARPIN 1 (-)-DICENTRINE 1 (-)-DOLICHIN-A 1 (-)-DOLICHIN-B 1 (-)-EPIAFZELECHIN 2 (-)-EPICATECHIN 6 (-)-EPICATECHIN-3-O-GALLATE 2 (-)-EPICATECHIN-GALLATE 1 (-)-EPIGALLOCATECHIN 4 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 9 (-)-EUDESMIN 1 (-)-GLYCEOCARPIN 1 (-)-GLYCEOFURAN 1 (-)-GLYCEOLLIN-I 1 (-)-GLYCEOLLIN-II 1 2 Chemical Activity Count (-)-GLYCEOLLIN-III 1 (-)-GLYCEOLLIN-IV 1 (-)-GLYCINOL 1 (-)-HYDROXYJASMONIC-ACID 1 (-)-ISOSATIVAN 1 (-)-JASMONIC-ACID 1 (-)-KAUR-16-EN-19-OIC-ACID 1 (-)-MEDICARPIN 1 (-)-VESTITOL 1 (-)-VESTITONE 1
    [Show full text]
  • A Systematic Review of Randomised Controlled Trials Examining Curcuma Longa for Dementia
    International Journal of Complementary & Alternative Medicine Literature Review Open Access A systematic review of randomised controlled trials examining Curcuma longa for dementia Abstract Volume 13 Issue 6 - 2020 Curcuma longa has been used to treat several ailments traditionally, such as rheumatoid Shivani P Shah, Genevieve Z. Steiner arthritis, conjunctivitis, skin cancer, small pox, chicken pox, wound healing, urinary tract 1NICM, Western Sydney University, Penrith NSW 2751, Australia infections and liver ailments. Due to its therapeutic properties, it has recently grown in popularity as a potential adjunct therapy for dementia. However, no systematic review Correspondence: Shivani P Shah, Western Sydney University, of randomised controlled trials has been conducted to evaluate its efficacy and safety Locked Bag 1797, Penrith NSW 2751, USA, for cognitive decline. In this dissertation, literature searches were conducted using Email four electronic databases, including PubMed Central, Science Direct, CINAHL, and PsycINFO. We retrieved five published studies which were randomised control trials and Received: September 21, 2020 | Published: December 31, have included these in the review. Search terms used were ‘dementia’, ‘Alzheimer*’, 2020 ‘ageing’, ‘mild cognitive impairment’, ‘cognitive decline’, ‘turmeric’ and ‘curcuma longa’. Efficacy measures such as biochemical markers, neuropsychological assessments, and pharmacological measures have been extracted from studies and synthesised in the review. Although several in vitro and in vivo model studies have found neuroprotective effects of curcumin in Alzheimer’s disease, there is not sufficient evidence to support curcumin use in humans with Alzheimer’s disease, and healthy volunteers. Short term usage of curcumin has been found to be safe. Various reasons such as its low bioavailability and inconsistency in study designs were responsible for discrepancies between preclinical findings and human trials.
    [Show full text]